Wenjing Yu

3.0k citations
73 papers · 2.2k indexed · h-index 24
Topics
Mesenchymal stem cell research (8 papers)Glaucoma and retinal disorders (4 papers)Lung Cancer Treatments and Mutations (4 papers)
Journals
NatureJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Wenjing Yu

65 papers receiving 2.2k citations

Peers

Wenjing Yu
Comparison fields: 5 of 137
  • Molecular Biology 877
  • Genetics 321
  • Cancer Research 307
  • Oncology 305
  • Infectious Diseases 288
Replace Bobby Yanagawa with:
Bobby Yanagawa Canada
Chang‐Woo Lee South Korea
Andrew H. Kang United States
Jiamin Zhang China
Chi‐Neu Tsai Taiwan
Chun‐Liang Chen Taiwan
Günther F.L. Hofbauer Switzerland
Immo Rantala Finland
Mark Yen‐Ping Kuo Taiwan
Liying Wang China
Wenjing Yu relative to Bobby Yanagawa Canada Bobby Yanagawa's profile →
Citations per field
00.5×1.5×
Bobby Yanagawa · 1×
Citations per year

Countries citing papers authored by Wenjing Yu

Since Specialization
Citations

This map shows the geographic impact of Wenjing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjing Yu more than expected).

Fields of papers citing papers by Wenjing Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjing Yu. The network helps show where Wenjing Yu may publish in the future.

Co-authorship network of co-authors of Wenjing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjing Yu. A scholar is included among the top collaborators of Wenjing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjing Yu. Wenjing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 5
5 1
6 0
7 1
8 2
9 15
10 6
11 22
12 5
13 8
14 3
15 59
16 46
17 50
18 53
19
CNR1 and risk of the metabolic syndrome in patients with schizophrenia
1
20 156

About Wenjing Yu

Wenjing Yu is a scholar working on Genetics, Complementary and Manual Therapy and Immunology, having authored 73 papers that have together received 2.2k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (8 papers), Glaucoma and retinal disorders (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Genetics (321 citations), Cancer Research (307 citations) and Animal Science and Zoology (198 citations). Wenjing Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Bing Sun, Chider Chen, Kai Wang, Xiaoxing Kou, Shiqi Xie, Wolfgang Schwarz, Ruili Yang, Silvia Schwarz, Songtao Shi and James J. Chou. Their work appears in journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026